Cargando…

Clinical Profiles and Mortality of COVID‐19 Inpatients with Parkinson's Disease in Germany

BACKGROUND: Comprehensive, nationwide data regarding Parkinson's disease (PD) hospitalizations, coronavirus disease 2019 (COVID‐19) in‐hospital frequency, and COVID‐19‐associated inpatient mortality during the first wave of the COVID‐19 pandemic are not available. OBJECTIVE: To provide a nation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scherbaum, Raphael, Kwon, Eun Hae, Richter, Daniel, Bartig, Dirk, Gold, Ralf, Krogias, Christos, Tönges, Lars
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Special Series Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207013/ https://www.ncbi.nlm.nih.gov/pubmed/33942924 http://dx.doi.org/10.1002/mds.28586

Ejemplares similares

Analysis of nationwide multimodal complex treatment and drug pump therapy in Parkinson's disease in times of COVID-19 pandemic in Germany
por: Richter, Daniel, et al.
Publicado: (2021)

COVID-19 outcomes in hospitalized Parkinson’s disease patients in two pandemic waves in 2020: a nationwide cross-sectional study from Germany
por: Scherbaum, Raphael, et al.
Publicado: (2022)

Hospital Admissions for Neurodegenerative Diseases during the First Wave of the COVID-19 Pandemic: A Nationwide Cross-Sectional Study from Germany
por: Scherbaum, Raphael, et al.
Publicado: (2021)

Letter to the editor: risk comorbidities of COVID-19 in Parkinson’s disease patients in Germany
por: Richter, Daniel, et al.
Publicado: (2020)

Inpatient care of neuromyelitis optica spectrum disorder in Germany: Nationwide analysis from 2010 to 2021
por: Richter, Daniel, et al.
Publicado: (2023)

Dynamics of Parkinson’s Disease Multimodal Complex Treatment in Germany from 2010–2016: Patient Characteristics, Access to Treatment, and Formation of Regional Centers
por: Richter, Daniel, et al.
Publicado: (2019)

Multiple sclerosis is not associated with an increased risk for severe COVID-19: a nationwide retrospective cross-sectional study from Germany
por: Richter, Daniel, et al.
Publicado: (2021)

The impact of the COVID-19 pandemic on hospitalizations and plasmapheresis therapy in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide analysis from Germany
por: Richter, Daniel, et al.
Publicado: (2021)

Hospitalization Rates and Comorbidities in Patients with Progressive Supranuclear Palsy in Germany from 2010 to 2017
por: Zella, Maria Angela Samis, et al.
Publicado: (2020)

Brainstem Raphe Alterations in TCS: A Biomarker for Depression and Apathy in Parkinson's Disease Patients
por: Richter, Daniel, et al.
Publicado: (2018)

Inpatient TIA and stroke care in adult patients in Germany - retrospective analysis of nationwide administrative data sets of 2011 to 2017
por: Eyding, Jens, et al.
Publicado: (2019)

Letter to the Editor: Analysis of stroke patient migration for mechanical thrombectomy and changes in neurointerventional center size in Germany
por: Weber, Ralph, et al.
Publicado: (2021)

Parkinson’s Disease Multimodal Complex Treatment (PD-MCT): Analysis of Therapeutic Effects and Predictors for Improvement
por: Hartelt, Elke, et al.
Publicado: (2020)

Acute ischemic stroke care in Germany – further progress from 2016 to 2019
por: Richter, Daniel, et al.
Publicado: (2021)

A full year of the COVID‐19 pandemic with two infection waves and its impact on ischemic stroke patient care in Germany
por: Richter, Daniel, et al.
Publicado: (2021)

Data-driven subtyping of Parkinson’s disease: comparison of current methodologies and application to the Bochum PNS cohort
por: Chen, Qiang, et al.
Publicado: (2023)

Update on CSF Biomarkers in Parkinson’s Disease
por: Kwon, Eun Hae, et al.
Publicado: (2022)

Parkinson’s disease multimodal complex treatment improves gait performance: an exploratory wearable digital device-supported study
por: Scherbaum, Raphael, et al.
Publicado: (2022)

Distribution and evolution of acute interventional ischemic stroke treatment in Germany from 2010 to 2016
por: Weber, Ralph, et al.
Publicado: (2019)

Comparison of stroke care parameters in acute ischemic stroke patients with and without concurrent Covid-19. A Nationwide analysis
por: Richter, Daniel, et al.
Publicado: (2020)

Monogenetic Forms of Parkinson’s Disease – Bridging the Gap Between Genetics and Biomarkers
por: Tönges, Lars, et al.
Publicado: (2022)

Prevalence and Characteristics of Polyneuropathy in Atypical Parkinsonian Syndromes: An Explorative Study
por: Rohmann, Rachel, et al.
Publicado: (2021)

Lentiform Nucleus Hyperechogenicity in Parkinsonian Syndromes: A Systematic Review and Meta-Analysis with Consideration of Molecular Pathology
por: Richter, Daniel, et al.
Publicado: (2019)

Concerns Raised by Publication of Antonini et al., “Outcome of Parkinson Disease Patients Affected by Covid‐19”
por: Raphael, Karen G.
Publicado: (2020)

The impact of regional deprivation on stroke incidence, treatment, and mortality in Germany
por: Belau, Matthias Hans, et al.
Publicado: (2023)

Building a Parkinson-Network–Experiences from Germany
por: van Munster, Marlena, et al.
Publicado: (2020)

Propionic Acid and Fasudil as Treatment against Rotenone Toxicity in an In Vitro Model of Parkinson’s Disease
por: Ostendorf, Friederike, et al.
Publicado: (2020)

Risk of Hospitalization and Death for COVID‐19 in People with Parkinson's Disease or Parkinsonism
por: Vignatelli, Luca, et al.
Publicado: (2020)

Parkinson's Disease and Post–COVID‐19 Syndrome: The Parkinson's Long‐COVID Spectrum
por: Leta, Valentina, et al.
Publicado: (2021)

Safety of Plasma Infusions in Parkinson's Disease
por: Parker, Jordan E., et al.
Publicado: (2020)

Emerging Immunotherapies for Parkinson Disease
por: Zella, Samis M. A., et al.
Publicado: (2018)

SARS-CoV-2, COVID-19 and Parkinson’s Disease—Many Issues Need to Be Clarified—A Critical Review
por: Goerttler, Tsepo, et al.
Publicado: (2022)

Covid Proof Self‐Management Training for Caregivers of Patients with Parkinson's Disease
por: Duits, Annelien A., et al.
Publicado: (2020)

Phenomenology and Outcomes of In‐Patients With Parkinson's Disease During the Coronavirus Disease 2019 Pandemic
por: Kobylecki, Christopher, et al.
Publicado: (2020)

Recommendations for Standards of Network Care for Patients with Parkinson’s Disease in Germany
por: Prell, Tino, et al.
Publicado: (2020)

Mechanical Thrombectomy for Acute Ischemic Stroke in Patients with Malignancy: A Systematic Review
por: Aloizou, Athina-Maria, et al.
Publicado: (2022)

Specialized Staff for the Care of People with Parkinson’s Disease in Germany: An Overview
por: Prell, Tino, et al.
Publicado: (2020)

Successful therapy with rituximab in three patients with probable neurosarcoidosis
por: Zella, Samis, et al.
Publicado: (2018)

Clostridium difficile in Discharged Inpatients, Germany
por: Vonberg, Ralf-Peter, et al.
Publicado: (2007)

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
por: Zella, Maria Angela Samis, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9jiu6gm8js0tdue0hgrs0oatj5